Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression

被引:10
|
作者
Wang, Maggie [1 ]
Peter, Samson S. [2 ]
Chu, Chi D. [3 ,4 ]
Tuot, Delphine S. [3 ,4 ,5 ]
Chen, Jonathan H. [6 ,7 ]
机构
[1] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Div Nephrol, Priscilla Chan & Mark Zuckerberg San Francisco Ge, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Ctr Innovat Access & Qual, San Francisco, CA 94143 USA
[6] Stanford Univ, Stanford Ctr Biomed Informat Res, 3180 Porter Dr,Room B132, Stanford, CA 94305 USA
[7] Stanford Univ, Dept Med, Div Hosp Med, 3180 Porter Dr,Room B132, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
GLOMERULAR-FILTRATION-RATE; ALBUMINURIA; MORTALITY; FAILURE;
D O I
10.1001/jamanetworkopen.2022.25797
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Identification of patients with chronic kidney disease (CKD) with high risk of progression to kidney failure can help ensure they receive appropriate and effective nephrology care. OBJECTIVE To examine whether patients with CKD at various levels of kidney failure risk receive nephrology care within 1 year of established risk. DESIGN, SETTING, AND PARTICIPANTS This population-based, retrospective cohort study collected nationwide administrative health claims data from 156 733 adult patients who met the Kidney Disease: Improving Global Outcomes initiative CKD diagnostic criteria between January 1, 2012, and December 31, 2019, and had an available urine albumin to creatinine ratio within 90 days of a serum creatinine laboratory test. Patients with a history of dialysis or kidney transplant, a prior visit with a nephrologist in the past year, or palliative care billing codes or those who died or disenrolled within 1 year of the albumin to creatinine ratio measurement were excluded. Data analysis was performed from September 10, 2022, to February 14, 2022. EXPOSURES Kidney failure risk computed with the 5-year Kidney Failure Risk Equation. MAIN OUTCOMES AND MEASURES The main outcome was nephrology care rates across tiers of kidney failure risk, estimated as the proportion of individuals having a nephrologist visit within 1 year after index time. RESULTS The study population consisted of 156 733 patients with CKD (mean [SD] age, 74.6 [8.4] years; 91906 [58.6%] female; 86 457 [55.2%] White). A total of 106 004 patients (67.6%) had a low (<= 1%) 5-year risk of kidney failure. Nephrology visit rates increased with higher kidney failure risk. Among the 137 highest-risk patients, 79 (57.7%; 95% CI, 48.4%-64.7%) had a nephrology visit. Among 7730 patients with risk above a 10% threshold, 3208 (41.5%; 95% CI, 40.3%-42.4%) had a nephrology visit. CONCLUSIONS AND RELEVANCE This study's findings suggest that nearly half of patients with CKD at high risk of progressing to kidney failure do not have a nephrologist visit within 1 year of established risk. These findings have implications in the design of risk-based guidelines for referral and in the practice of delivering nephrology care to patients with CKD.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study
    Gayoso-Diz, Pilar
    Otero-Gonzalez, Alfonso
    Xose Rodriguez-Alvarez, M.
    Garcia, Fernando
    Gonzalez-Quintela, Arturo
    Martin-de Francisco, Angel L.
    NEFROLOGIA, 2013, 33 (02): : 223 - 230
  • [2] Albuminuria testing and nephrology care among insured US adults with chronic kidney disease: a missed opportunity
    Chu, Chi D.
    Powe, Neil R.
    Shlipak, Michael G.
    Scherzer, Rebecca
    Tummalapalli, Sri Lekha
    Estrella, Michelle M.
    Tuot, Delphine S.
    BMC PRIMARY CARE, 2022, 23 (01):
  • [3] Risk factor analysis for a rapid progression of chronic kidney disease
    Vestergaard, Anne H. S.
    Jensen, Simon K.
    Heide-Jorgensen, Uffe
    Frederiksen, Line E.
    Birn, Henrik
    Jarbol, Dorte E.
    Sondergaard, Jens
    Persson, Frederik
    Thomsen, Reimar W.
    Christiansen, Christian F.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (07) : 1150 - 1158
  • [4] Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease
    Provenzano, Michele
    Maritati, Federica
    Abenavoli, Chiara
    Bini, Claudia
    Corradetti, Valeria
    La Manna, Gaetano
    Comai, Giorgia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [5] Chronic Kidney Disease And Associated Risk Factors Among Cardiovascular Patients
    Chala, Getahun
    Sisay, Tariku
    Teshome, Yonas
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2019, 12 : 205 - 211
  • [6] Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease
    Fernandez-Fernandez, Beatriz
    Mahillo, Ignacio
    Sanchez-Rodriguez, Jinny
    Carriazo, Sol
    Sanz, Ana B.
    Sanchez-Nino, Maria Dolores
    Ortiz, Alberto
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [7] Risk factors for progression of chronic kidney disease
    Staples, Amy
    Wong, Craig
    CURRENT OPINION IN PEDIATRICS, 2010, 22 (02) : 161 - 169
  • [8] Prevalence of Chronic Kidney Disease in Patients With or at a High Risk of Cardiovascular Disease
    Cases Amenos, Aleix
    Gonzalez-Juanatey, Jose R.
    Conthe Gutierrez, Pedro
    Matali Gilarranz, Arantxa
    Garrido Costa, Cristina
    REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (02): : 225 - 228
  • [9] Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care
    Provenzano, Michele
    Minutolo, Roberto
    Chiodini, Paolo
    Bellizzi, Vincenzo
    Nappi, Felice
    Russo, Domenico
    Borrelli, Silvio
    Garofalo, Carlo
    Iodice, Carmela
    De Stefano, Toni
    Conte, Giuseppe
    Heerspink, Hiddo J. L.
    De Nicola, Luca
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [10] High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients
    Kanda, Eiichiro
    Ai, Masumi
    Yoshida, Masayuki
    Kuriyama, Renjiro
    Shiigai, Tatsuo
    BMC NEPHROLOGY, 2013, 14